Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.06.2017 | Case report

Furosemide/sodium chloride

Osmotic demyelination syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat De Vecchis R, et al. Over-correction of symptomatic hyponatremia in chronic HF that required specific therapeutic adjustments against possible osmotic demyelination syndrome. An apparently counter intuitive approach. European Journal of Heart Failure 19 (Suppl. 1): 195 abstr. 831, May 2017. Available from: URL: http://doi.org/10.1002/ejhf.833 [abstract] - Italy De Vecchis R, et al. Over-correction of symptomatic hyponatremia in chronic HF that required specific therapeutic adjustments against possible osmotic demyelination syndrome. An apparently counter intuitive approach. European Journal of Heart Failure 19 (Suppl. 1): 195 abstr. 831, May 2017. Available from: URL: http://​doi.​org/​10.​1002/​ejhf.​833 [abstract] - Italy
Metadaten
Titel
Furosemide/sodium chloride
Osmotic demyelination syndrome: case report
Publikationsdatum
01.06.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-31200-5

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Alteplase

Case report

Amiodarone

Case report

Pazopanib

Case report

Multiple drugs